GENEVA, April 6 -- CYTOVATION ASA (Solheimsgaten 115058 Bergen) filed a patent application (PCT/EP2024/077155) for "TREATMENT OF CANCERS ASSOCIATED WITH BETA-CATENIN" on Sep 26, 2024. With publication no. WO/2025/068426, the details related to the patent application was published on Apr 03, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PRESTEGARDEN, Lars (Solheimsgaten 115058 Bergen), BJERKVIK, Rolf (Solheimsgaten 115058 Bergen)
Abstract:
The present invention provides an oligopeptidic compound, CyPep-1, for use in the treatment of cancers associated with aberrant activation of the Wnt/...